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This commentary proposes a mechanism for why
murine diabetic adipose tissue contains very few
remaining stem cells compared with normal adipose
tissue. The mechanism involves the diversion of stem
cells to pathological adipocytes when they divide in
hyperglycemia.ments extrudes the hyaluronan macromolecule into the
endoplasmic reticulum (ER), transport vesicles, and theThe interesting and important study by Rennert and col-
leagues [1], 'Diabetes impairs the angiogenic potential of
adipose derived stem cells by selectively depleting cellu-
lar subpopulations', investigated properties of stem cells
isolated from adipose tissue from normal and diabetic
type 1 and type 2 obese mice. Their data show that adi-
pose tissue from both types of diabetes contain signifi-
cantly fewer stem cells that normally can form
osteogenic and adipogenic progeny as well as a greatly
decreased selective subpopulation that can participate in
angiogenic processes such as wound healing. The au-
thors conclude that 'these data suggest that the utility of
autologous adipose tissue cells for cell-based therapies in
diabetic patients may be limited'. As adipose tissue is
now considered a very useful source of autologous stem
cells for various translational therapies, this study pro-
vides strong evidence that adipose tissue from diabetics
will have far fewer stem cells.
Our studies and others provide clues for the mecha-
nisms involved. We have now shown that rat bone mar-
row stromal (stem) cells stimulated to divide in
osteogenic medium in which the glucose concentration
was increased from normal (5 mM) to hyperglycemic
(25 mM) diverted to a pathological adipogenesis [2]. The
mechanism involves activation of hyaluronan synthases
(HASs) in intracellular membrane compartments. The* Correspondence: hascalv@ccf.org
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2014HASs utilize cytosolic substrates, UDP-glucuronate and
UDP-N-acetylglucosamine, and synthesis of hyaluronan
is an effective way to lower influxed cytosolic glucose
stress [3]. The HAS enzymes normally migrate to the
plasma membrane before activation, and the elongating,
polyanionic, very large hyaluronan macromolecules are
extruded into the extracellular pericellular matrix. Acti-
vation of HASs in intracellular membrane compart-
Golgi. This initiates a unique autophagic ER stress
mechanism that extrudes the hyaluronan into a
monocyte-adhesive extracellular matrix after completing
cell division. This mechanism also occurs with stromal/
stem cells in trabecular bone of type 1 diabetic rats with
subsequent osteopenia [2]. This provides evidence that a
stem cell that divides in hyperglycemia produces two
daughter pathological adipocytes with loss of a stem cell
that would normally occur if the division were
asymmetric.
The study by Chang and colleagues [4] showed that
sections of adipose tissue from the obese mice, but not
from normal mice, had extensive extracellular hyaluro-
nan matrices around the adipocytes. The matrix was em-
bedded with Mac-2 macrophages that likely were
recruited to remove the hyaluronan matrix, which would
otherwise accumulate indefinitely as the adipocytes
would continue to synthesize and extrude hyaluronan in
response to sustained hyperglycemia. The ability of
monocytes/macrophages to remove the monocyte-
adhesive matrix has been shown as described in the re-
view [5]. This mechanism also appears to be active in
kidney mesangial cells in type 1 diabetic rats that were
treated daily with a small intraperitoneal dose of hep-
arin, which sustains kidney function in this model [6].
Our proposed model, then, is that stem cells that div-
ide in hyperglycemia (>2.5 times normal) divert to a
pathological adipogenesis in response to the glucose
stress, and that subsequent cell divisions along thisntral Ltd. The licensee has exclusive rights to distribute this article, in any
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ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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fat cells in adipose tissue in diabetes. Further, this mech-
anism is occurring in other tissues that contribute to
diabetic pathologies, including osteopenia, impaired
wound healing, aberrant vascularization in necrotic feet,
and so on. As indicated recently in an interesting article
in the magazine Time, 'Don’t blame fat' [7], it is the high
carbohydrate, low fat Western diet that is greatly con-
tributing to the ongoing epidemic of diabetes and
obesity.
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